• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻冠心病患者的传统和非传统心血管危险因素概况

Traditional and non-traditional cardiovascular risk factor profiles in young patients with coronary artery disease.

作者信息

Adhikari Anish, DeJesus Sasha, Swe Nyein, Vaidean Georgeta, Nahrwold Rachel, Joshua John, Carrero-Tagle Monique, Wutawanashe Caleb, Hentz Roland, Lesser Martin, Gianos Eugenia

机构信息

Northwell, New Hyde Park, NY, Cardiovascular Institute, Lenox Hill Hospital, USA.

Cardiovascular Prevention Forum, Miami, FL, USA.

出版信息

Am Heart J Plus. 2024 Oct 11;47:100471. doi: 10.1016/j.ahjo.2024.100471. eCollection 2024 Nov.

DOI:10.1016/j.ahjo.2024.100471
PMID:39473786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11513663/
Abstract

STUDY OBJECTIVE

There is an increasing trend in myocardial infarction (MI) hospitalizations in young individuals. The prevalence of modifiable cardiovascular risk factors is high in this population. This study aims to assess the prevalence of traditional and non-traditional cardiovascular risk factors among young patients with coronary artery disease (CAD) including novel lipid and dietary biomarkers with a focus on potential gender differences.

DESIGN

The Young Heart study is a prospective, single-center pilot cohort study. Baseline data included medical history, medications, and lifestyle factors. We also collected blood samples for lipid profile, lipoprotein (a), high-sensitivity C-reactive protein (hsCRP), and trimethylamine N-oxide (TMAO).

PARTICIPANTS

A total of 60 patients aged <60 years with CAD (on coronary CT or invasive angiogram) were included in the study.

RESULTS

The median age was 51 years and predominantly male (70 %). Baseline assessment revealed a high prevalence of hypertension (76.7 %), hyperlipidemia (91.7 %), and obstructive CAD (88.3 %). 36.7 % had diabetes, 28.3 % had prediabetes, and 38.3 % had prior MI. Uncontrolled risk factors were prevalent, including increased waist circumference (54.6 %), metabolic syndrome (60.0 %), and LDL ≥70 mg/dL (47.5 %), Lp(a) ≥75 nmol/L (47.5 %). Furthermore, 41.7 % had hsCRP ≥2 mg/L, and 28.3 % had suboptimal TMAO levels. 70.0 % of patients were on guideline-directed doses of statins.

CONCLUSION

Young patients with CAD demonstrated a substantial burden of traditional and non-traditional cardiovascular risk factors. The study findings highlight the need for targeted interventions to improve risk factor control and optimize lifestyle behaviors. Further investigation is warranted to assess the impact of these interventions on cardiovascular outcomes.

摘要

研究目的

年轻人因心肌梗死(MI)住院的趋势呈上升态势。这一人群中可改变的心血管危险因素的患病率很高。本研究旨在评估年轻冠心病(CAD)患者中传统和非传统心血管危险因素的患病率,包括新型脂质和饮食生物标志物,并重点关注潜在的性别差异。

设计

“年轻心脏”研究是一项前瞻性、单中心的试点队列研究。基线数据包括病史、用药情况和生活方式因素。我们还采集了血样以检测血脂谱、脂蛋白(a)、高敏C反应蛋白(hsCRP)和氧化三甲胺(TMAO)。

参与者

本研究共纳入60例年龄小于60岁的CAD患者(经冠状动脉CT或侵入性血管造影确诊)。

结果

中位年龄为51岁,男性占主导(70%)。基线评估显示高血压患病率高(76.7%)、高脂血症患病率高(91.7%)以及阻塞性CAD患病率高(88.3%)。36.7%患有糖尿病,28.3%患有糖尿病前期,38.3%曾发生过MI。未得到控制的危险因素普遍存在,包括腰围增加(54.6%)、代谢综合征(60.0%)以及低密度脂蛋白≥70mg/dL(47.5%)、脂蛋白(a)≥75nmol/L(47.5%)。此外,41.7%的患者hsCRP≥2mg/L,28.3%的患者TMAO水平未达最佳。70.0%的患者接受了指南推荐剂量的他汀类药物治疗。

结论

年轻CAD患者表现出传统和非传统心血管危险因素的沉重负担。研究结果强调需要进行有针对性的干预,以改善危险因素控制并优化生活方式行为。有必要进一步开展研究以评估这些干预措施对心血管结局的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6142/11513663/17f86b2d4cb1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6142/11513663/17f86b2d4cb1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6142/11513663/17f86b2d4cb1/gr1.jpg

相似文献

1
Traditional and non-traditional cardiovascular risk factor profiles in young patients with coronary artery disease.年轻冠心病患者的传统和非传统心血管危险因素概况
Am Heart J Plus. 2024 Oct 11;47:100471. doi: 10.1016/j.ahjo.2024.100471. eCollection 2024 Nov.
2
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.冠心病的一级预防:新数据整合、观点演变、目标修订以及瑞舒伐他汀在管理中的作用。一项全面综述。
Drug Des Devel Ther. 2011;5:325-80. doi: 10.2147/DDDT.S14934. Epub 2011 Jun 13.
3
Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.LURIC研究的基本原理与设计——心血管疾病功能基因组学、药物基因组学及长期预后的资源
Pharmacogenomics. 2001 Feb;2(1 Suppl 1):S1-73. doi: 10.1517/14622416.2.1.S1.
4
5
Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity.脂蛋白(a)升高对冠状动脉疾病表型和严重程度的影响。
Eur J Prev Cardiol. 2024 May 11;31(7):856-865. doi: 10.1093/eurjpc/zwae007.
6
Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population.可改变的生活方式风险因素与冠心病患者的 C-反应蛋白:抗炎治疗目标人群的意义。
Eur J Prev Cardiol. 2021 Apr 10;28(2):152–158. doi: 10.1177/2047487319885458. Epub 2019 Nov 10.
7
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial.C 反应蛋白对高血管风险疾病经优化治疗患者脂蛋白(a)相关心血管风险的影响:ACCELERATE 试验的一项预设次要分析。
JAMA Cardiol. 2020 Oct 1;5(10):1136-1143. doi: 10.1001/jamacardio.2020.2413.
8
9
Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention.脂蛋白(a)、高敏C反应蛋白与接受经皮冠状动脉介入治疗患者的心血管风险
Atherosclerosis. 2022 Dec;363:109-116. doi: 10.1016/j.atherosclerosis.2022.10.013. Epub 2022 Oct 25.
10
Association of Lipoprotein (a) in Coronary Artery Disease in Young Individuals.载脂蛋白(a)与青年人群冠状动脉疾病的相关性。
J Assoc Physicians India. 2022 Apr;70(4):11-12.

本文引用的文献

1
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee.2022年美国心脏病学会解决方案集监督委员会关于非他汀类疗法在降低低密度脂蛋白胆固醇以管理动脉粥样硬化性心血管疾病风险中的作用的专家共识决策路径报告。
J Am Coll Cardiol. 2022 Oct 4;80(14):1366-1418. doi: 10.1016/j.jacc.2022.07.006. Epub 2022 Aug 25.
2
Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association.《生命的基础 8:更新和强化美国心脏协会心血管健康构建:美国心脏协会主席特别咨询报告》。
Circulation. 2022 Aug 2;146(5):e18-e43. doi: 10.1161/CIR.0000000000001078. Epub 2022 Jun 29.
3
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.《心脏病与卒中统计-2022 更新:美国心脏协会报告》。
Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
4
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 ACC/AHA/SCAI 冠状动脉血运重建指南:执行摘要:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2022 Jan 18;145(3):e4-e17. doi: 10.1161/CIR.0000000000001039. Epub 2021 Dec 9.
5
Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.早发性冠状动脉疾病患者中的家族性高胆固醇血症、家族性混合型高脂血症和脂蛋白(a)升高
Can J Cardiol. 2021 Nov;37(11):1733-1742. doi: 10.1016/j.cjca.2021.08.012. Epub 2021 Aug 26.
6
Adverse Trends in Premature Cardiometabolic Mortality in the United States, 1999 to 2018.美国 1999 年至 2018 年过早的心血代谢死亡率呈下降趋势。
J Am Heart Assoc. 2020 Dec;9(23):e018213. doi: 10.1161/JAHA.120.018213. Epub 2020 Nov 23.
7
Association of diet with circulating trimethylamine-N-oxide concentration.饮食与循环中三甲胺 N-氧化物浓度的关系。
Am J Clin Nutr. 2020 Dec 10;112(6):1448-1455. doi: 10.1093/ajcn/nqaa225.
8
Colchicine in Patients with Chronic Coronary Disease.秋水仙碱治疗慢性冠心病
N Engl J Med. 2020 Nov 5;383(19):1838-1847. doi: 10.1056/NEJMoa2021372. Epub 2020 Aug 31.
9
Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry.风险因素和非常年轻的心肌梗死患者的预后:伙伴 YOUNG-MI 注册研究。
Am J Med. 2020 May;133(5):605-612.e1. doi: 10.1016/j.amjmed.2019.10.020. Epub 2019 Nov 9.
10
Diabetes Is Associated With Worse Long-term Outcomes in Young Adults After Myocardial Infarction: The Partners YOUNG-MI Registry.糖尿病与心肌梗死后年轻成年人长期预后不良相关:Partners YOUNG-MI 登记研究。
Diabetes Care. 2020 Aug;43(8):1843-1850. doi: 10.2337/dc19-0998. Epub 2019 Sep 23.